Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Hungerford

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Histopathology|October 31, 2001
Differential immunoreactivity of melanocytic lesions of the conjunctivaN A Sharara, R A Alexander, P J Luthert, et al.
Melanoma Research|June 4, 1998
The prognostic significance of c-myc oncogene expression in uveal melanomaJ S Chana, I A Cree, A J Foss, et al.
Eye (London, England)|March 27, 2002
Primary orbital melanoma masquerading as vascular anomaliesV Lee, C Sandy, G E Rose, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Side effects of photon and proton radiotherapy for ocular melanomaJ L Hungerford, A J Foss, I Whelahan, et al.
Ophthalmology|December 31, 1997
Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapyS A Madreperla, J L Hungerford, P N Plowman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Ocular radioimmunoscintigraphy: sensitivity and practical considerationsJ Bomanji, C C Nimmon, J L Hungerford, et al.
Eye (London, England)|September 17, 2005
Proton beam therapy and iris neovascularisation in uveal melanomaS R Boyd, A Gittos, M Richter, et al.
Cancer Research|July 1, 1996
Microvessel count predicts survival in uveal melanomaA J Foss, R A Alexander, L W Jefferies, et al.
Ophthalmology|March 1, 1995
Estrogen and progesterone receptor analysis in ocular melanomasA J Foss, R A Alexander, M J Guille, et al.
The British Journal of Ophthalmology|March 1, 1997
Reassessment of the PAS patterns in uveal melanomaA J Foss, R A Alexander, J L Hungerford, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Histopathology|October 31, 2001
Differential immunoreactivity of melanocytic lesions of the conjunctivaN A Sharara, R A Alexander, P J Luthert, et al.
Melanoma Research|June 4, 1998
The prognostic significance of c-myc oncogene expression in uveal melanomaJ S Chana, I A Cree, A J Foss, et al.
Eye (London, England)|March 27, 2002
Primary orbital melanoma masquerading as vascular anomaliesV Lee, C Sandy, G E Rose, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Side effects of photon and proton radiotherapy for ocular melanomaJ L Hungerford, A J Foss, I Whelahan, et al.
Ophthalmology|December 31, 1997
Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapyS A Madreperla, J L Hungerford, P N Plowman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Ocular radioimmunoscintigraphy: sensitivity and practical considerationsJ Bomanji, C C Nimmon, J L Hungerford, et al.
Eye (London, England)|September 17, 2005
Proton beam therapy and iris neovascularisation in uveal melanomaS R Boyd, A Gittos, M Richter, et al.
Cancer Research|July 1, 1996
Microvessel count predicts survival in uveal melanomaA J Foss, R A Alexander, L W Jefferies, et al.
Ophthalmology|March 1, 1995
Estrogen and progesterone receptor analysis in ocular melanomasA J Foss, R A Alexander, M J Guille, et al.
The British Journal of Ophthalmology|March 1, 1997
Reassessment of the PAS patterns in uveal melanomaA J Foss, R A Alexander, J L Hungerford, et al.
Pageof 10